ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00710528
Recruitment Status : Completed
First Posted : July 4, 2008
Last Update Posted : August 31, 2012
Sponsor:
Information provided by:
Gilead Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2011
  Actual Study Completion Date : August 2012
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):